Neumora Therapeutics, Inc.

This study is testing whether a new oral medication called NMRA-335140 can help reduce symptoms of major depression. About 332 adults with moderate to severe depression will take either the medication or a placebo pill for 6 weeks. Researchers will measure changes in depression s…

This study is testing whether a new oral medication called NMRA-335140 can reduce symptoms of major depression. Over 6 weeks, 332 adults with moderate-to-severe depression will receive either the active drug or a placebo pill, with neither participants nor doctors knowing which i…

This study aims to learn about the long-term safety and effectiveness of an investigational drug called NMRA-335140 for people with major depressive disorder. It is a one-year extension study for up to 1,000 participants who have already completed a shorter, earlier phase of rese…